Photo source: Africa news
Pfizer and BioNTech laboratories are about to enter the final stage of the production of their vaccines against Covid-19 in Cape Town, South Africa, from 2022, so that they can the vaccine production is in bulk and is sufficient to supply the African continent where the lack of doses slows down the immunization campaigns. The U.S.-German duo has partnered with the Biovac Group with the goal of supplying up to 100 million doses per year “exclusively” to the 55 “African Union member countries,” according to a statement detailing the alliance’s first partnership outside Europe and North America.
All the equipment and technical supporting machines will be transported soon. “This is a crucial step in strengthening sustainable access to vaccines” and the collaboration “will enable wider distribution of doses to people in hard-to-reach communities, especially on the African continent,” commented Morena Makhoana, CEO of Biovac.
Data source: Africa news
Nigeria’s leading music figure and vocalist, Cobhams Asuquo, known for his singing and production said…
Following a mixed reaction from the South African community representatives, Khoi and San, the Cape…
Mitigating the process and service barriers in African rail transportation, the digital disruption has transformed…
Kais Saied, the Tunisian president has said in his speech that he will allow the…
You know the credibility of an ingredient when it’s plastered all over bottles and jars…
Cyclone Gombe that flooded large areas of central and northern Mozambique is consistently leading to…
This website uses cookies.